TG Therapeutics第三季度每股收益2.43美元超过0.22美元预期，销售额1.61709亿美元超过1.52169亿美元预期

TG Therapeutics (NASDAQ: TGTX) reported quarterly earnings of $2.43 per share which beat the analyst consensus estimate of $0.22 by 999.55 percent. This is a 12050 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $161.709 million which beat the analyst consensus estimate of $152.169 million by 6.27 percent. This is a 92.79 percent increase over sales of $83.879 million the same period last year.